Perinatal exposure to Δ9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: A behavioral study in rats

Pharmacology Biochemistry and Behavior

Volumn 75, Issue 3, 2003, Pages 565-575

  Moreno, Margarita ^a   Trigo, Jose Manuel ^a   Escuredo, Leticia ^b   Rodríguez de Fonseca, Fernando ^b   Navarro, Miguel ^a  

^a Campus de Somosaguas   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Apomorphine; Behaviour; Cannabinoid; Dopamine receptors; Perinatal exposure; Quinpirole

Indexed keywords

APOMORPHINE; DOPAMINE 2 RECEPTOR; DRONABINOL; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; GESTATIONAL AGE; LACTATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0043199793     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(03)00117-5     Document Type: Article

References (58)

1. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet. 26:1987;1483-1486.
2. Arevalo C., De Miguel R., Hernandez-Tristan R. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol. Biochem. Behav. 70:2001;123-131.
3. 2 receptor responses by anandamide transport inhibitor. J. Neurosci. 20:2000;3401-3407.
4. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernández-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse. 33:1999;181-191.
5. 9-tetrahydrocannabinol affects gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 56:1995;2177-2184.
6. Day N.L., Richardson G.A., Goldschmidt L., Robles N., Taylor P.M., Stoffer D.S.et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol. Teratol. 16:1994;169-175.
7. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterisation of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
8. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson R.G., Griffin G.et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
9. Di Marzo V., Melck D., Bisogno T., De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21:1998;521-528.
10. 9-tetrahydrocannabinol-tolerant rats. J. Neurochem. 74:2000;1627-1635.
11. Di Marzo V., Hill M.P., Bisogno T., Crossman A.R., Brotchie J.M. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J. 14:2000;1432-1438.
12. Eilam D., Szechtman H. Biphasic effect of D2 agonist quinpirole on locomotion and movements. Eur. J. Pharmacol. 161:1989;151-157.
13. Fernandez-Ruiz J.J., Bonnin A., Cebeira M., Ramos J.A. Ontogenic and adult changes in the activity of hypothalamic and extrahypothalamic dopaminergic neurons after perinatal cannabinoid exposure in rats. Palomo T., Archer T. Strategies for studying brain disorders. 1994;357-390 Farrand Press, London.
14. Fernandez-Ruiz J.J., Berrendero F., Hernández M.L., Ramos J.A. The endogenous cannabinoid system and brain development. Trends Neurosci. 23:2000;14-20.
15. Frantz K.J., Van Hartesveldt C. Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats. Psychopharmacology. 119:1995;299-304.
16. Fride E., Mechoulam R. Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology. 21:1996;157-172.
17. Fried P.A., Smith A.M. A literature review of the consequences of prenatal marihuana exposure, an emerging theme of a deficiency in aspects of executive function. Neurotoxicol. Teratol. 23:2001;1-11.
18. Gardner E.L., Lowinson J.M. Marijuana's interaction with brain reward system: update 1991. Pharmacol. Biochem. Behav. 40:1991;571-580.
19. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2:1999;358-363.
20. 9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats. Eur. J. Pharmacol. 365:1999;133-142.
21. Gubellini P., Picconi B., Bari M., Battista N., Calbresi P., Centoze D.et al. J. Neurosci. 22:2002;6900-6907.
22. Gurnack A.M., Paul W. Factors related to perinatal substance abuse in California County. Percept. Mot. Skills. 84:1997;1403-1408.
23. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., De Costa B.R.et al. Cannabinoid receptor localization in the brain. Proc. Natl. Acad. Sci. 87:1990;1932-1936.
24. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
25. Hernandez M., Berrendero F., Suarez I., Garcia-Gil L., Cebeira M., Mackie K.et al. Cannabinoid CB(1) receptors colocalize with tyrosine hydroxilase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme. Brain Res. 28:2000;56-65.
26. Howlet A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
27. Hutchings D.E., Martin B.R., Gamagaris Z., Miller N., Fico T. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44:1989;697-701.
28. 14C-tetrahydrocannabinol to the mother. Eur. J. Pharmacol. 22:1977;221-223.
29. Levitt P. Prenatal effects of drug abuse on brain development. Drug Alcohol Depend. 51:1998;109-125.
30. Martin M., Ledent C., Parmentier M., Maldonado R., Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology. 159:2002;379-387.
31. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
32. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R.et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:1995;83-90.
33. 1 dopamine receptor agonists potentiate cannabinoid induced sedation in nonhuman primates. J. Pharmacol. Exp. Ther. 292:2000;952-959.
34. Navarro M., Rodriguez de Fonseca F. Early cannabinoid exposure as a source of vulnerability to opiate addiction: a model in laboratory rodents. Span. J. Psychol. 1:1998;39-58.
35. 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity. Behav. Brain Res. 5:1993;37-46.
36. 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav. 45:1993;291-298.
37. Navarro M., Rodriguez de Fonseca F., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Motor behavior on nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 47:1994;47-58.
38. 9-tetrahydrocannabinol. An ontogenic study in Wistar rats. Psychopharmacology. 116:1994;414-422.
39. Navarro M., Rubio P., Rodriguez de Fonseca F. Behavioral consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology. 122:1995;1-14.
40. Navarro M., De Miguel R., Rodriguez de Fonseca F., Ramos J.A., Fernández-Ruiz J.J. Perinatal cannabinoid exposure modifies sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats. Behav. Brain Res. 75:1996;91-98.
41. Picetti R., Saiardi A., Abdel Samad T., Bozzi Y., Baik J.H., Borrelli E. Dopamine D2 receptors in signal transduction and behavior. Crit. Rev. Neurobiol. 11:1997;121-142.
42. Robins L.N., Mills J.L. Effects of in utero exposure to street drugs. Am. J. Public Health Suppl. 83:1993;8-32.
43. Rodriguez de Fonseca F., Cebeira M., Fernandez Ruiz J.J., Navarro M., Ramos J.A. Effects of pre and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
44. 9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacol. Biochem. Behav. 42:1992;269-275.
45. Rodriguez de Fonseca F., Hernandez M.L., De Miguel R., Fernández-Ruiz J.J., Ramos J.A. Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids. Pharmacol. Biochem. Behav. 41:1992;469-474.
46. Rodriguez de Fonseca F., Ramos J.A., Bonnin A., Fernández-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport. 4:1993;135-138.
47. 8-tetrahydrocannabinol-dimethylheptyl- induced catalepsy in male rats. NeuroReport. 5:1994;761-765.
48. 9-tetrahydrocannabinol toxicity in rats treated for periods up to six months. Toxicol. Appl. Pharmacol. 32:1975;399-417.
49. 9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring. Pharmacol. Biochem. Behav. 61:1998;229-238.
50. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22:2001;565-572.
51. Suarez I., Bodega G., Ramos J.A., Fernandez-Ruiz J.J., Fernandez B. Neuronal and astroglial response to pre and perinatal exposure to delta-9-tetrahydrocannabinol in the rat substantia nigra. Dev. Neurosci. 22:1999;253-263.
52. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K.et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215:1995;89-97.
53. Usiello A., Baik J.H., Rouge-Pont F., Picetti R., Dierich A., LeMeur M.et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 408:2000;199-203.
54. Walters D.E., Carr L.A. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol. Biochem. Behav. 25:1986;763-778.
55. Walters D.E., Carr L.A. Perinatal exposure to cannabinoids alter neurochemical development in the rat brain. Pharmacol. Biochem. Behav. 29:1988;213-216.
56. Williams C.M., Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology. 143:1999;315-317.
57. Yarbrough G.G., McGuffin-Clineschmidt J., Singh D.K., Haubrich D.R., Bendesky R.J., Martin G.E. Electrophysiological, biochemical and behavioral assessment of dopamine autoreceptor activation by a series of dopamine agonists. Eur. J. Pharmacol. 16:1984;73-78.
58. Zuckerman B., Frank D.A., Hingson R., Amaro H., Levenson S.M., Kayne H.et al. Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. 320:1989;762-768.